These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18312490)

  • 1. Influence of CYP2C19*18 and CYP2C19*19 alleles on omeprazole 5-hydroxylation: in vitro functional analysis of recombinant enzymes expressed in Saccharomyces cerevisiae.
    Hanioka N; Tsuneto Y; Saito Y; Maekawa K; Sawada J; Narimatsu S
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):388-93. PubMed ID: 18312490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population.
    Hanioka N; Tsuneto Y; Saito Y; Sumada T; Maekawa K; Saito K; Sawada J; Narimatsu S
    Xenobiotica; 2007 Apr; 37(4):342-55. PubMed ID: 17455109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Functional Characterisation of Cytochrome P450 (CYP) 2C19 Allelic Variants CYP2C19*23 and CYP2C19*24.
    Lau PS; Leong KV; Ong CE; Dong AN; Pan Y
    Biochem Genet; 2017 Feb; 55(1):48-62. PubMed ID: 27578295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S-mephenytoin 4'-hydroxylation and omeprazole 5'-hydroxylation.
    Wang H; An N; Wang H; Gao Y; Liu D; Bian T; Zhu J; Chen C
    Drug Metab Dispos; 2011 May; 39(5):830-7. PubMed ID: 21325430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.
    Shon JH; Yoon YR; Kim MJ; Kim KA; Lim YC; Liu KH; Shin DH; Lee CH; Cha IJ; Shin JG
    Br J Clin Pharmacol; 2005 May; 59(5):552-63. PubMed ID: 15842554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.
    Griskevicius L; Yasar U; Sandberg M; Hidestrand M; Eliasson E; Tybring G; Hassan M; Dahl ML
    Eur J Clin Pharmacol; 2003 Jun; 59(2):103-9. PubMed ID: 12684728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
    Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
    Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of CYP2C8.13 and CYP2C8.14: catalytic activities toward paclitaxel.
    Hanioka N; Matsumoto K; Saito Y; Narimatsu S
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):565-9. PubMed ID: 20148860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques.
    Uno Y; Matsushita A; Shukuya M; Matsumoto Y; Murayama N; Yamazaki H
    Biochem Pharmacol; 2014 Sep; 91(2):242-8. PubMed ID: 25036290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective hexobarbital 3'-hydroxylation by CYP2C19 expressed in yeast cells and the roles of amino acid residues at positions 300 and 476.
    Saito K; Dan H; Masuda K; Katsu T; Hanioka N; Yamamoto S; Miyano K; Yamano S; Narimatsu S
    Chirality; 2007 Jul; 19(7):550-8. PubMed ID: 17487889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.
    Wang JH; Li PQ; Fu QY; Li QX; Cai WW
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):421-4. PubMed ID: 17439410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease.
    Ohnishi A; Murakami S; Akizuki S; Mochizuki J; Echizen H; Takagi I
    J Clin Pharmacol; 2005 Nov; 45(11):1221-9. PubMed ID: 16239354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.
    Giraud C; Tran A; Rey E; Vincent J; Tréluyer JM; Pons G
    Drug Metab Dispos; 2004 Nov; 32(11):1279-86. PubMed ID: 15483195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes.
    Abelö A; Andersson TB; Antonsson M; Naudot AK; Skånberg I; Weidolf L
    Drug Metab Dispos; 2000 Aug; 28(8):966-72. PubMed ID: 10901708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the cytochrome P450 2C19 genetic polymorphism.
    Desta Z; Zhao X; Shin JG; Flockhart DA
    Clin Pharmacokinet; 2002; 41(12):913-58. PubMed ID: 12222994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomer/enantiomer interactions between the S- and R- isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4.
    Li XQ; Weidolf L; Simonsson R; Andersson TB
    J Pharmacol Exp Ther; 2005 Nov; 315(2):777-87. PubMed ID: 16093273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
    Chiba K; Kobayashi K; Manabe K; Tani M; Kamataki T; Ishizaki T
    J Pharmacol Exp Ther; 1993 Jul; 266(1):52-9. PubMed ID: 8331574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
    Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.